Oren Zimhony
- Infectious Diseases top 1%
- Tuberculosis Research and Epidemiology 14
- COVID-19 Clinical Research Studies 8
- SARS-CoV-2 and COVID-19 Research 7
- Amoebic Infections and Treatments 4
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria 12
- Parasitology top 5%
- Virology top 5%
-
- Mycobacterium research and diagnosis 10
- Pneumocystis jirovecii pneumonia detection and treatment 6
- Pneumonia and Respiratory Infections 4
- Co-authors
- William R. JacobsCatherine VilchèzeJohn T. WelchJeffery S. CoxAmi SchattnerMichael GiladiMichal ChowersBoaz Avidor
- Partner nations
- IsraelUnited StatesUnited Kingdom
In The Last Decade
Oren Zimhony
61 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 128
- Applied Microbiology and Biotechnology 107
- Infectious Diseases 965
- Molecular Medicine 153
- Parasitology 180
- Virology 80
Countries citing papers authored by Oren Zimhony
This map shows the geographic impact of Oren Zimhony's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oren Zimhony with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oren Zimhony more than expected).
Fields of papers citing papers by Oren Zimhony
This network shows the impact of papers produced by Oren Zimhony. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oren Zimhony. The network helps show where Oren Zimhony may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Oren Zimhony, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 9 | |
| 4 | 2023 | 9 | |
| 5 | 2022 | 25 | |
| 6 | 2022 | 4 | |
| 7 | 2020 | 5 | |
| 8 | 2018 | 14 | |
| 9 | 2018 | 4 | |
| 10 | 2015 | 10 | |
| 11 | 2015 | 9 | |
| 12 | 2013 | 11 | |
| 13 | 2009 | 41 | |
| 14 | 2009 | 14 | |
| 15 | 2008 | 8 | |
| 16 | 2008 | 3 | |
| 17 | 2005 | 11 | |
| 18 | 2004 | 3 | |
| 19 | 1996 | 11 | |
| 20 | 1994 | 14 |
About Oren Zimhony
Oren Zimhony is a scholar working on Molecular Medicine, Infectious Diseases and Applied Microbiology and Biotechnology, having authored 62 papers that have together received 1.7k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (14 papers), Antibiotic Resistance in Bacteria (12 papers), Mycobacterium research and diagnosis (10 papers), COVID-19 Clinical Research Studies (8 papers), SARS-CoV-2 and COVID-19 Research (7 papers), Pneumocystis jirovecii pneumonia detection and treatment (6 papers), Amoebic Infections and Treatments (4 papers) and Pneumonia and Respiratory Infections (4 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (107 citations), Infectious Diseases (965 citations) and Molecular Medicine (153 citations). Oren Zimhony has collaborated with scholars based in Israel, United States and United Kingdom. Frequent co-authors include William R. Jacobs, Catherine Vilchèze, John T. Welch, Jeffery S. Cox, Ami Schattner, Michael Giladi, Michal Chowers, Boaz Avidor, Bibiana Chazan and Yonit Wiener‐Well. Their work appears in journals such as The Lancet, Nature Medicine and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.